Biohacking News by Zestology podcast

Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685

0:00
32:50
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

Yet more GLP1 news this week. 

People regain on average 60% of their lost weight within a year of stopping GLP-1 drugs — and the regained weight may be disproportionately fat rather than muscle. 

So are a tool that biohackers have known about for years - CGMs - the answer? 

Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared glucose system for weight management.

Follow Sharam Fouladgar-Mercer on LinkedIn.

Fler avsnitt från "Biohacking News by Zestology"